GENERAL COUNSEL
Wed, May 15, 2024
May 15
exercised or converted securities in DAWN
3,687 shares @ $0.00
Decreased holdings by -6.70%
Net across this filing: +31.00% (+5,146 shares)
Option Exercise
Sale tied to a same-time option exercise
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology